Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - Foundation Medicine, Inc. | fmi-ex321_446.htm |
EX-31.2 - EX-31.2 - Foundation Medicine, Inc. | fmi-ex312_447.htm |
EX-31.1 - EX-31.1 - Foundation Medicine, Inc. | fmi-ex311_448.htm |
EX-23.1 - EX-23.1 - Foundation Medicine, Inc. | fmi-ex231_360.htm |
EX-21.1 - EX-21.1 - Foundation Medicine, Inc. | fmi-ex211_249.htm |
EX-10.24 - EX-10.24 - Foundation Medicine, Inc. | fmi-ex1024_251.htm |
EX-10.11 - EX-10.11 - Foundation Medicine, Inc. | fmi-ex1011_250.htm |
10-K - 10-K - Foundation Medicine, Inc. | fmi-10k_20161231.htm |
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-3 No. 333-200613) of Foundation Medicine, Inc.,
(2) Registration Statement (Form S-8 No. 333-191380) pertaining to the Amended and Restated 2010 Stock Incentive Plan, the 2013 Stock Option and Incentive Plan and the 2013 Employee Stock Purchase Plan of Foundation Medicine, Inc., and
(3) Registration Statement (Form S-8 Nos. 333-194439 and 333-201756) pertaining to the 2013 Stock Option and Incentive Plan of Foundation Medicine, Inc.;
of our report dated March 13, 2015, with respect to the consolidated financial statements of Foundation Medicine, Inc. as of December 31, 2014 and for each of the two years in the period ended December 31, 2014 included in this Annual Report (Form 10-K) of Foundation Medicine, Inc. for the year ended December 31, 2016.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 2, 2017